August 16, 2024
TOPLINE: Patients with coeliac disease commonly have osteoporosis and sustain fractures. The Fracture Risk Assessment Tool (FRAX) may help target bone health testing in this population. […]
August 16, 2024
People who live with at least two other people in their first year of life and have a dog during childhood may be at reduced risk […]
August 16, 2024
A new stool-based syndecan-2 methylation (mSDC2) test may improve the detection of colorectal cancer (CRC) and advanced colorectal neoplasia (ACN), based on a prospective, real-world study. […]
August 16, 2024
TOPLINE: Misoprostol is highly effective in treating small bowel injuries caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin, whereas rebamipide offers modest protection against such injuries, […]
August 16, 2024
(Reuters) – British drugmaker GSK said on Friday it would seek a dismissal of an upcoming Zantac case in Florida, where plaintiffs alleged that its discontinued […]
August 14, 2024
The US Food and Drug Administration (FDA) granted accelerated approval for Livdelzi (seladelpar, Gilead Sciences, Inc.) for primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid […]
August 14, 2024
TOPLINE: Acute gastroenteritis increases the odds of developing functional dyspepsia (FD) and irritable bowel syndrome (IBS), with the latter lasting 1-4 years in half of patients […]
August 14, 2024
In late July, the US Food and Drug Administration (FDA) approved the first use of a liquid biopsy (blood test) for colorectal cancer (CRC) screening. The […]
August 13, 2024
TOPLINE: Fecal immunochemical test (FIT) screening reduces colorectal cancer (CRC) mortality by 33% overall, with a notable 42% reduction in deaths from left colon and rectal […]